Related Experiment Video
Updated: Aug 23, 2025
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
Generation of the human pluripotent stem cell lines KUMi005-A from a patients with multiple myeloma
Ji-Hea Kim1, Ji-Hyeon Hong2, Ka-Won Kang3
1Institute of Stem Cell Research, Korea University College of Medicine, Seoul, South Korea; Department of Biomedical and Science, Graduate School of Medicine, Korea University, Seoul, South Korea.
Abstract:
Multiple myeloma (MM) progresses with abnormal monoclonal proliferation and accumulation of malignant plasma cells in the bone marrow. We established human induced pluripotent stem cells (iPSCs), KUMi005-A, from bone marrow samples of a patient with MM. This reprogrammed cell line has similar characteristics to human embryonic stem cells, such as proliferation properties and pluripotency. KUMi005-A iPSCs may be applicable in MM disease modeling and cell-based therapies.
Insights
Researchers created induced pluripotent stem cells (iPSCs) from a multiple myeloma (MM) patient. These KUMi005-A iPSCs show potential for MM disease modeling and developing new cell-based therapies.
Area of Science:
- Stem cell biology
- Hematology
- Oncology
Background:
- Multiple myeloma (MM) is characterized by malignant plasma cell proliferation in bone marrow.
- Understanding MM pathogenesis and developing effective therapies remain critical challenges.
Purpose of the Study:
- To establish and characterize human induced pluripotent stem cells (iPSCs) from a patient with multiple myeloma (MM).
- To evaluate the potential of these iPSCs for MM disease modeling and therapeutic applications.
Main Methods:
- Generation of induced pluripotent stem cells (iPSCs) from bone marrow samples of an MM patient.
- Characterization of iPSC pluripotency and proliferation properties.
- Assessment of KUMi005-A iPSC characteristics compared to human embryonic stem cells.
Main Results:
- Successfully established a novel human iPSC line, designated KUMi005-A, from MM patient-derived bone marrow.
- KUMi005-A iPSCs exhibit characteristics comparable to human embryonic stem cells, including robust proliferation and pluripotency.
- The established iPSC line serves as a valuable tool for studying MM.
Conclusions:
- The KUMi005-A iPSC line represents a significant advancement in MM research.
- These iPSCs hold promise for developing accurate in vitro models for multiple myeloma.
- Potential applications include facilitating the discovery of novel therapeutic strategies and cell-based treatments for MM.
